Skip to content

13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 11 holding rows worth $148,065,879.

Accession
0001012975-25-000081
Filed
2025-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 11 entries on the cover page, a total value of $148,065,879 stated on the cover page (in dollars after the unit check, H1), rows summing to $148,065,879 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VAXCYTE INC COM92243G108Stock703,834$57,615,851dollars as filed
OCULIS HOLDING AGH5870P102CMN1,737,696$29,540,832dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM2,120,508$29,538,676dollars as filed
INOZYME PHARMA INC45790W108COM4,494,851$12,450,737dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock736,645$6,033,123dollars as filed
RECURSION PHARMACEUTICALS IN75629V104CL A595,518$4,025,702dollars as filed
BIOAGE LABS INC COM09077V100Stock653,374$3,783,035dollars as filed
RALLYBIO CORP75120L100COM2,404,644$2,308,458dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,891,467$1,021,392dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM560,595$953,012dollars as filed
IO BIOTECH INC449778109COM864,197$795,061dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-25-000081this filing2025-02-13acceptance time not in the bulk data set